Evelien Moorkens:
ORCID: http://orcid.org/0000-0002-9570-470X
Role: InvestigationRole: MethodologyRole: Writing – original draftRole: Writing –
review & editing
Arnold G. Vulto: Role: ConceptualizationRole: SupervisionRole: Writing – review & editing
Isabelle Huys: Role: ConceptualizationRole: SupervisionRole: Writing – review & editing
Pieter Dylst: Role: ConceptualizationRole: Writing – review & editing
Brian Godman: Role: ConceptualizationRole: MethodologyRole: Writing – review & editing
Simon Keuerleber: Role: InvestigationRole: Writing – review & editing
Barbara Claus: Role: InvestigationRole: Writing – review & editing
Maria Dimitrova: Role: InvestigationRole: Writing – review & editing
Guenka Petrova: Role: InvestigationRole: Writing – review & editing
Ljiljana Sović-Brkičić: Role: InvestigationRole: Writing – review & editing
Juraj Slabý: Role: InvestigationRole: Writing – review & editing
Robin Šebesta: Role: InvestigationRole: Writing – review & editing
Ott Laius: Role: InvestigationRole: Writing – review & editing
Allan Karr: Role: InvestigationRole: Writing – review & editing
Morgane Beck: Role: InvestigationRole: Writing – review & editing
Jaana E. Martikainen: Role: InvestigationRole: Writing – review & editing
Gisbert W. Selke: Role: InvestigationRole: Writing – review & editing
Susan Spillane: Role: InvestigationRole: Writing – review & editing
Laura McCullagh: Role: InvestigationRole: Writing – review & editing
Gianluca Trifirò: Role: InvestigationRole: Writing – review & editing
Patricia Vella Bonanno: Role: InvestigationRole: Writing – review & editing
Asbjørn Mack: Role: InvestigationRole: Writing – review & editing
Antra Fogele: Role: InvestigationRole: Writing – review & editing
Anita Viksna: Role: InvestigationRole: Writing – review & editing
Magdalena Władysiuk: Role: InvestigationRole: Writing – review & editing
Helder Mota-Filipe: Role: InvestigationRole: Writing – review & editing
Dmitry Meshkov: Role: InvestigationRole: Writing – review & editing
Marija Kalaba: Role: InvestigationRole: Writing – review & editing
Simona Mencej Bedrač: Role: InvestigationRole: Writing – review & editing
Jurij Fürst: Role: InvestigationRole: Writing – review & editing
Corrine Zara: Role: InvestigationRole: Writing – review & editing
Peter Skiöld: Role: InvestigationRole: Writing – review & editing
Einar Magnússon: Role: InvestigationRole: Writing – review & editing
Steven Simoens: Role: ConceptualizationRole: MethodologyRole: SupervisionRole: Writing – review &
editing
Tomasz Bochenek: Role: Editor
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
28
December
2017
Publication date Collection: 2017
Volume: 12
Issue: 12
Electronic Location Identifier: e0190147
Affiliations
[1
]
KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium
[2
]
Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands
[3
]
Medicines for Europe, Brussels, Belgium
[4
]
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
[5
]
Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde,
Glasgow, United Kingdom
[6
]
Main Association of Austrian Social Security Institutions, Vienna, Austria
[7
]
Faculty of pharmaceutical sciences, Ghent University, Ghent, Belgium
[8
]
Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
[9
]
Croatian Health Insurance Fund, Zagreb, Croatia
[10
]
State Institute for Drug Control, Prague, Czech Republic
[11
]
State Institute for Drug Control, Brno, Czech Republic
[12
]
State Agency of Medicines, Tartu, Estonia
[13
]
Department of Traumatology and Orthopedics, University of Tartu, Tartu, Estonia
[14
]
Karr Consultancy Ltd, Hertfordshire, United Kingdom
[15
]
OMEDIT Alsace, Agence Régionale de Santé du Grand Est, Strasbourg, France
[16
]
Research Unit, Social Insurance Institution, Helsinki, Finland
[17
]
Wissenschaftliches Institut der AOK (WIdO), Berlin, Germany
[18
]
Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland
[19
]
National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland
[20
]
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University
of Messina, Messina, Italy
[21
]
Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde,
Glasgow, United Kingdom
[22
]
Division Pharmaceuticals, Norwegian Hospital Procurement Trust, Oslo, Norway
[23
]
Department of Medicines and Medical Devices, The National Health Service, Riga, Latvia
[24
]
HTA Consulting, Cracow, Poland
[25
]
Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
[26
]
Semashko National Research Institute for Public Health, Moscow, Russia
[27
]
Primary healthcare center Zemun, Belgrade, Serbia
[28
]
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, Ljubljana,
Slovenia
[29
]
Health Insurance Institute, Ljubljana, Slovenia
[30
]
Barcelona Health Region, Catalan Health Service, Barcelona, Spain
[31
]
TLV, Stockholm, Sweden
[32
]
Ministry of Welfare, Reykjavik, Iceland
Jagiellonian University, POLAND
Author notes
Competing Interests: Steven Simoens, Isabelle Huys, and Arnold G. Vulto are the founders of the KU Leuven
Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity.
Steven Simoens, Isabelle Huys, and Arnold G. Vulto are conducting biosimilar research
sponsored by Hospira (now Pfizer). Steven Simoens is involved in a stakeholder roundtable
on biosimilars sponsored by Amgen, Pfizer and MSD, and has participated in an advisory
board meeting on biosimilars for Pfizer. Arnold G. Vulto is involved in consulting,
advisory work and speaking engagements for a number of companies, a.o. AbbVie, Amgen,
Biogen, EGA, Pfizer/Hospira, Mundipharma, Roche, Sandoz. Pieter Dylst was employed
full-time by Medicines for Europe at the time of the study and did not receive any
honoraria from pharmaceutical companies. Gianluca Trifirò participated in the last
five years in expert meeting boards organized by Sandoz and Hospira. Simona Mencej
Bedrač declares that she was an employee of Lek Pharmaceuticals d. d. (Sandoz group).
All remaining authors declare that the research was conducted in the absence of any
commercial or financial relationships that could be construed as a potential conflict
of interest. These interests do not alter our adherence to PLOS ONE policies on sharing
data and materials.
Author information
Article
Publisher ID:
PONE-D-17-26394
DOI: 10.1371/journal.pone.0190147
PMC ID: 5746224
PubMed ID: 29284064
SO-VID: bbd5f6e7-8d64-4b78-9b55-5eb1925eda35
Copyright © © 2017 Moorkens et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
The authors received no specific funding for this work.
Subject:
Research Article
Subject:
People and Places
Subject:
Population Groupings
Subject:
Professions
Subject:
Medical Personnel
Subject:
Medical Doctors
Subject:
Physicians
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Providers
Subject:
Medical Doctors
Subject:
Physicians
Subject:
People and Places
Subject:
Geographical Locations
Subject:
Europe
Subject:
Biology and Life Sciences
Subject:
Physiology
Subject:
Biological Locomotion
Subject:
Walking
Subject:
Medicine and Health Sciences
Subject:
Physiology
Subject:
Biological Locomotion
Subject:
Walking
Subject:
People and Places
Subject:
Population Groupings
Subject:
Professions
Subject:
Medical Personnel
Subject:
Pharmacists
Subject:
People and places
Subject:
Geographical locations
Subject:
Europe
Subject:
European Union
Subject:
Social Sciences
Subject:
Sociology
Subject:
Communications
Subject:
Marketing
Subject:
Social Sciences
Subject:
Economics
Subject:
Commerce
Subject:
Procurement
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Providers
Subject:
Allied Health Care Professionals
